Cardiff Oncology, Inc.
CRDF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $206,801 | $66,122 | $61,040 | $234,570 |
| - Cash | $51,470 | $21,655 | $16,347 | $11,943 |
| + Debt | $1,523 | $2,149 | $2,715 | $3,119 |
| Enterprise Value | $156,854 | $46,616 | $47,408 | $225,746 |
| Revenue | $683 | $488 | $386 | $359 |
| % Growth | 40% | 26.4% | 7.5% | – |
| Gross Profit | $683 | $488 | $386 | $359 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$48,247 | -$45,014 | -$39,666 | -$28,404 |
| % Margin | -7,064% | -9,224.2% | -10,276.2% | -7,912% |
| Net Income | -$45,431 | -$41,441 | -$38,704 | -$28,291 |
| % Margin | -6,651.7% | -8,492% | -10,026.9% | -7,880.5% |
| EPS Diluted | -0.95 | -0.93 | -0.89 | -0.73 |
| % Growth | -2.2% | -4.5% | -21.9% | – |
| Operating Cash Flow | -$37,693 | -$30,887 | -$33,820 | -$23,040 |
| Capital Expenditures | -$80 | -$582 | -$892 | -$205 |
| Free Cash Flow | -$37,773 | -$31,469 | -$34,712 | -$23,245 |